Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Financing › Details

Heidelberg Pharma–SEVERAL: investment, 202202–202208 capital increase €79.91m with €76.24m thereof from Huadong Medicine reaching 25% shareholding

 

Period Period 2022-02-27 � 2022-08-30
Organisations Money taker Heidelberg Pharma AG (FSE: HPHA)
  Group Heidelberg Pharma (Group)
  Money source SEVERAL
Products Product HDP-101 (Heidelberg Pharma)
  Product 2 finance
Document Source Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg.
     

   
Record changed: 2024-02-21

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Heidelberg Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top